These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 10758202)

  • 1. The Insertion/Deletion Polymorphism of the Angiotensin-Converting Enzyme Gene and the Risk for Restenosis After PTCA.
    Völzke H; Hertwig S; Rettig R
    Int J Angiol; 2000 Mar; 9(2):82-86. PubMed ID: 10758202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The angiotensinogen gene 235T variant is associated with an increased risk of restenosis after percutaneous transluminal coronary angioplasty.
    Völzke H; Hertwig S; Rettig R; Motz W
    Clin Sci (Lond); 2000 Jul; 99(1):19-25. PubMed ID: 10887054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insertion/deletion polymorphism in the angiotensin-converting enzyme gene and risk of restenosis after coronary angioplasty.
    Samani NJ; Martin DS; Brack M; Cullen J; Chauhan A; Lodwick D; Harley A; Swales JD; de Bono DP; Gershlick AH
    Lancet; 1995 Apr; 345(8956):1013-6. PubMed ID: 7723497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relation between the deletion polymorphism of the angiotensin-converting enzyme gene and late luminal narrowing after coronary angioplasty.
    Hamon M; Bauters C; Amant C; McFadden EP; Helbecque N; Lablanche JM; Bertrand ME; Amouyel P
    Circulation; 1995 Aug; 92(3):296-9. PubMed ID: 7634441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin-converting enzyme and apolipoprotein E genotypes and restenosis after coronary angioplasty.
    van Bockxmeer FM; Mamotte CD; Gibbons FA; Burke V; Taylor RR
    Circulation; 1995 Oct; 92(8):2066-71. PubMed ID: 7554183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between angiotensin converting enzyme gene polymorphism, coronary artery disease, and stent restenosis: the role of angiotensin converting enzyme inhibitors in stent restenosis in patients with diabetes mellitus.
    Guneri S; Baris N; Aytekin D; Akdeniz B; Pekel N; Bozdemir V
    Int Heart J; 2005 Sep; 46(5):889-97. PubMed ID: 16272779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of coronary in-stent restenosis: importance of angiotensin-converting enzyme gene polymorphism and treatment with angiotensin-converting enzyme inhibitors.
    Jørgensen E; Kelbaek H; Helqvist S; Jensen GV; Saunamäki K; Kastrup J; Havndrup O; Bundgaard H; Kyst Madsen J; Christiansen M; Andersen PS; Reiber JH
    J Am Coll Cardiol; 2001 Nov; 38(5):1434-9. PubMed ID: 11691520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacogenetic analysis of the effect of angiotensin-converting enzyme inhibitor on restenosis after percutaneous transluminal coronary angioplasty.
    Okamura A; Ohishi M; Rakugi H; Katsuya T; Yanagitani Y; Takiuchi S; Taniyama Y; Moriguchi K; Ito H; Higashino Y; Fujii K; Higaki J; Ogihara T
    Angiology; 1999 Oct; 50(10):811-22. PubMed ID: 10535720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ace D/I polymorphism and incidence of post-PTCA restenosis: a prospective, angiography-based evaluation.
    Zee RY; Fernandez-Ortiz A; Macaya C; Pintor E; Lindpaintner K; Fernandez-Cruz A
    Hypertension; 2001 Mar; 37(3):851-5. PubMed ID: 11244007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Restenosis after successful percutaneous transluminal coronary angioplasty: the Montreal Heart Institute experience.
    Guiteras Val P; Bourassa MG; David PR; Bonan R; Crépeau J; Dyrda I; Lespérance J
    Am J Cardiol; 1987 Jul; 60(3):50B-55B. PubMed ID: 2956844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Importance of stenosis morphology in the estimation of restenosis risk after elective percutaneous transluminal coronary angioplasty.
    Ellis SG; Roubin GS; King SB; Douglas JS; Cox WR
    Am J Cardiol; 1989 Jan; 63(1):30-4. PubMed ID: 2521196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic polymorphism of angiotensin converting enzyme and risk of coronary restenosis after percutaneous transluminal coronary angioplasties: evidence from 33 cohort studies.
    Wang S; Dai Y; Chen L; Dong Z; Chen Y; Li C; Zhong X; Lin W; Zhang J
    PLoS One; 2013; 8(9):e75285. PubMed ID: 24098690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does the new angiotensin converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty? Results of the MERCATOR study: a multicenter, randomized, double-blind placebo-controlled trial. Multicenter European Research Trial with Cilazapril after Angioplasty to Prevent Transluminal Coronary Obstruction and Restenosis (MERCATOR) Study Group.
    Circulation; 1992 Jul; 86(1):100-10. PubMed ID: 1535568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin converting enzyme DD genotype affects the changes of plasma plasminogen activator inhibitor-1 activity after primary percutaneous transluminal coronary angioplasty in acute myocardial infarction patients.
    Prisco D; Fatini C; Battaglini B; Gensini F; Fedi S; Falai M; Chioccioli M; Gori AM; Margheri M; Gensini GF
    Int J Clin Lab Res; 2000; 30(4):179-85. PubMed ID: 11289708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insertion/deletion polymorphism of the angiotensin I-converting enzyme gene is not associated with restenosis after coronary stent placement.
    Koch W; Kastrati A; Mehilli J; Böttiger C; von Beckerath N; Schömig A
    Circulation; 2000 Jul; 102(2):197-202. PubMed ID: 10889131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin-converting enzyme insertion/deletion polymorphism does not influence the restenosis rate after coronary stent implantation.
    Ferrari M; Mudra H; Grip L; Voudris V; Schächinger V; de Jaegere P; Rieber J; Hausmann D; Rothman M; Koschyk DH; Figulla HR;
    Cardiology; 2002; 97(1):29-36. PubMed ID: 11893827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relation between the insertion/deletion polymorphism of the angiotensin I converting enzyme gene and restenosis after coronary stenting.
    Gürlek A; Güleç S; Karabulut H; Bokesoy I; Tutar E; Pamir G; Alpman A; Toydemir R; Aras O; Oral D
    J Cardiovasc Risk; 2000 Dec; 7(6):403-7. PubMed ID: 11155292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin I-converting enzyme (ACE) inhibitors and restenosis after coronary artery stenting in patients with the DD genotype of the ACE gene.
    Koch W; Mehilli J; von Beckerath N; Böttiger C; Schömig A; Kastrati A
    J Am Coll Cardiol; 2003 Jun; 41(11):1957-61. PubMed ID: 12798565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical and angiographic course after coronary angioplasty. Analysis of predictor factors of restenosis].
    Sanz E; Domingo E; Moreno V; Angel J; Anivarro I; Alió J; Alijarde M; Soler-Soler J
    Rev Esp Cardiol; 1992 Nov; 45(9):568-77. PubMed ID: 1475495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoprotein E polymorphism does not predict risk of restenosis after coronary angioplasty.
    Samani NJ; Martin DS; Brack M; Cullen J; Wallis R; Lodwick D; Chauhan A; Harley A; Thompson JR; Gershlick AH; de Bono DP
    Atherosclerosis; 1996 Sep; 125(2):209-16. PubMed ID: 8842352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.